News Omidenepag Matches Latanoprost for Glaucoma by Medscape • 2021/11/15 • 0 Comments A phase 3 noninferiority trial shows omidenepag almost as efficacious, but with more side effects than latanoprost in people with glaucoma or intraocular hypertension. Medscape Medical News Full Story →